We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Baxter Launches At-Risk Generic During Appeal

Law360 (January 2, 2006, 12:00 AM EST) -- Baxter Healthcare Corp. has ignored an appeal by rival Abbott Laboratories to launch at risk a generic version of Abbot’s popular inhaled anesthetic Ultane in the United States, Europe and Japan...
To view the full article, register now.